People · Operator
Named in public records as an officer, director or promoter · active 2014–2016 · Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Serenity Pharmaceuticals LLC | — | Pharmaceuticals | Series A | $7.9M | $244.5M | 2016 |
| Prospect Park Capital Corp | — | Other | Pre-Seed | $261K | $6.0M | 2014 |
SAMUEL HERSCHKOWITZ at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside SAMUEL HERSCHKOWITZ on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| JEFFREY BARNES | 1 | 3 |
| Kyle Appleby | 1 | 3 |
| Joshua Kornberg | 1 | 3 |
| Steven Etkind | 1 | 1 |
| ROBBIE GROSSMAN | 1 | 1 |
| FRANK MANCUSO JR. | 1 | 1 |
| Alain Kodsi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.